Oct 14, 6:44 AM ET
At its October 14, 2026 Investor Day, Accenture furnished a presentation reporting fiscal 2026 results against its original guidance and setting multi-year ambitions for fiscal 2027 through 2029. Adjusted EPS of $13.97 and free cash flow of $11.6 billion came in above the original guidance ranges, and the company returned $11.5 billion to shareholders. The new ambitions call for mid-single-digit revenue growth in fiscal 2027 and 2028, mid to high-single-digit growth in 2029, and 10 to 30 basis points of margin expansion each year.
- FY26 adjusted EPS was $13.97, above the original guidance range of $13.52 to $13.90.
- FY26 free cash flow was $11.6 billion, versus original guidance of $9.8 billion to $10.5 billion.
- FY26 revenue grew 5% in local currency, at the top of the original 2% to 5% guidance range.
- Targets for FY27 to FY29 include 10 to 30 basis points of operating margin expansion each year and free cash flow of at least 1.1 times net income.
Read the filing on SEC.gov ↗
Oct 1, 6:42 AM ET
Accenture reported fourth-quarter fiscal 2026 revenue of $18.68 billion, up 6% in U.S. dollars and above its guided range of $17.75 billion to $18.40 billion. Full-year GAAP diluted EPS was $13.56, up 12%, and adjusted EPS was $13.97, up 8%. The company also guided fiscal 2027 GAAP diluted EPS to $14.39 to $14.81, which would be a 6% to 9% increase.
- Q4 fiscal 2026 revenue was $18.68 billion, up 6% in U.S. dollars and 7% in local currency, above the guided range of $17.75 billion to $18.40 billion.
- Full-year fiscal 2026 GAAP diluted EPS was $13.56, up 12% from $12.15; adjusted EPS was $13.97, up 8%.
- Fiscal 2027 outlook: revenue growth of 3% to 6% in local currency and GAAP diluted EPS of $14.39 to $14.81.
- Accenture returned $11.5 billion to shareholders in fiscal 2026, and declared a quarterly dividend of $1.71 per share payable November 13, 2026.
Read the filing on SEC.gov ↗
Jul 10, 3:13 PM ET
On July 10, 2026, Accenture Capital Inc., a wholly owned subsidiary, closed the sale of five series of notes with an aggregate public offering price of $4.997 billion and estimated net proceeds of about $4.979 billion before offering expenses. Accenture plc fully and unconditionally guarantees the notes, so the debt is backed by the parent company. The filing describes the financing and its terms but does not state how the proceeds will be used.
- Aggregate public offering price was $4.997 billion; estimated net proceeds were about $4.979 billion before offering expenses.
- Five series were sold: $300 million floating rate notes due 2029, $1.0 billion 4.750% notes due 2029, $1.5 billion 5.000% notes due 2031, $1.1 billion 5.300% notes due 2033 and $1.1 billion 5.600% notes due 2036.
- Underwriting agreement dated July 8, 2026, with BofA Securities, Barclays, Citigroup and J.P. Morgan as managers; notes were sold under a Form S-3 filed September 30, 2024.
Read the filing on SEC.gov ↗
Jun 23, 7:05 AM ET
Accenture said it increased its fiscal 2026 share repurchase program by $2 billion, to $7.5 billion in expected repurchases, with all purchases to be completed by August 31, 2026. The company said total planned fiscal 2026 shareholder returns, including dividends, are expected to reach $11.5 billion, and that roughly $1 billion of repurchase capacity would remain under the existing authorization afterward.
- Total expected fiscal 2026 share repurchases rise to $7.5 billion, a 62% increase year-over-year
- Expected fourth-quarter repurchases total $2.3 billion, including the $2 billion increase and $300 million previously planned
- Year-to-date shareholder returns through dividends and buybacks were $8.2 billion; planned fiscal 2026 total is $11.5 billion
- Repurchases are to be completed by August 31, 2026; the company will request new Board authorization in September 2026
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.